The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Chorionic Gonadotropin Market In 2026 And How Much Will It Reach By 2030?
The chorionic gonadotropin market has experienced robust growth in recent years. It is forecast to expand from $1.34 million in 2025 to $1.43 million in 2026, at a compound annual growth rate (CAGR) of 6.5%. The market’s historical growth can be attributed to the rise in infertility treatments, its well-established role in ovulation induction, an increase in male reproductive disorders, the development of hospital-based fertility programs, and its extensive clinical application over time.
The chorionic gonadotropin market size is anticipated to demonstrate robust growth over the next few years. It is projected to reach $1.82 million in 2030, driven by a compound annual growth rate (CAGR) of 6.2%. This expected increase during the forecast period can be attributed to the rising global infertility rates, the expansion of assisted reproductive technologies, increased awareness regarding male hormonal disorders, a boost in oncology diagnostic applications, and wider availability through retail pharmacies. Significant trends for the forecast period include an escalating use in assisted reproductive treatments, an expanding application in male hypogonadism therapy, a heightened demand for fertility hormone therapies, the extended diagnostic use as a tumor marker, and enhanced formulations coupled with improved dosage accuracy.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp
What Important Drivers Are Powering The Chorionic Gonadotropin Market Growth?
The growing incidence of infertility issues is projected to fuel the expansion of the chorionic gonadotropin market in the future. Infertility is defined as the incapacity to get pregnant after one year of consistent, unprotected sexual intercourse for couples under 35, or after six months for those aged 35 and above. The increasing occurrence of infertility is largely attributable to postponed childbearing, as many opt to have children later, along with lifestyle aspects like obesity and smoking that can adversely affect reproductive health. Chorionic Gonadotropin (hCG) finds application in fertility treatments to trigger ovulation in women, support the luteal phase for maintaining pregnancy, and stimulate testosterone production in men to enhance sperm count, thereby addressing diverse infertility challenges. For instance, in April 2023, the World Health Organization (WHO), a specialized agency based in Switzerland, reported that roughly 17.5% of the adult population, or 1 in 6 people globally, suffer from infertility, highlighting the pressing need for enhanced access to affordable, high-quality fertility care for those impacted. Consequently, the rising prevalence of infertility issues is stimulating the growth of the chorionic gonadotropin market.
What Segment Types Are Included In The Chorionic Gonadotropin Market Analysis?
The chorionic gonadotropin market covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin, Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Other Therapeutic Applications
4) By End User: Research Institutions, Pharmaceutical Companies
Which Trends Are Contributing To Changes In The Chorionic Gonadotropin Market?
Major companies operating in the chorionic gonadotropin market are focusing on developing innovative solutions, such as saliva-based pregnancy tests, to improve convenience, accuracy, and accessibility. A saliva-based pregnancy test refers to a non-invasive diagnostic method that detects pregnancy by analyzing a woman’s saliva for the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. For instance, in June 2023, Salignostics, an Israel-based biotech company, launched the world’s first saliva-based pregnancy test. This innovative product allows women to determine pregnancy using a saliva sample instead of urine, detecting the hormone hCG (human chorionic gonadotropin) with results available in just 5 to 15 minutes. Salistick offers a more comfortable and convenient testing experience, enabling users to test anywhere and share the moment with partners or loved ones.
Which Firms Are Competing In The Chorionic Gonadotropin Market?
Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals
Access The Complete Chorionic Gonadotropin Market Report:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report
Which Region Is The Dominant Market In The Chorionic Gonadotropin Market?
North America was the largest region in the chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model